相关实验视频

Updated: Jun 21, 2025

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
10:26

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells

Published on: January 20, 2019

12.2K

作为淋巴瘤瘤的潜在治疗点,GLP和G9a基因组甲基转移酶是GLP和G9a基因组甲基转移酶的潜在治疗点

Amandda Évelin Silva-Carvalho1, Luma Dayane Carvalho Filiú-Braga1, Gabriela Muller Reche Bogéa1

  • 1Hematology and Stem Cells Laboratory, Faculty of Health Sciences, University of Brasília, Brasilia, Brazil.

Cancer cell international
|July 12, 2024
PubMed
概括

基因组甲基转移酶G9a/EHMT2和GLP/EHMT1是淋巴细胞癌症的关键驱动因素. 用小分子抑制剂向这些表观遗传酶显示出新型癌症治疗的前景.

关键词:
急性淋巴细胞白血病 (Acute Lymphoblastic Leukemia) 是一种急性淋巴细胞白血病.慢性淋巴细胞白血病 慢性淋巴细胞白血病在G9a中,G9a是G9a.这是GLP,GLP就是GLP.淋巴细胞瘤新生体的发生.多发性骨髓瘤是一种多发性骨髓瘤.

更多相关视频

Direct Measurement of KDM1A Target Engagement Using Chemoprobe-based Immunoassays11:17

Direct Measurement of KDM1A Target Engagement Using Chemoprobe-based Immunoassays

Published on: June 13, 2019

7.3K
Analysis of Histone Antibody Specificity with Peptide Microarrays09:47

Analysis of Histone Antibody Specificity with Peptide Microarrays

Published on: August 1, 2017

40.2K

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K